Open AccessNicotinamide found to reduce the rate of nonmelanoma skin cancers in high‐risk patients
Author(s) -
Barton Mary Kay
Publication year - 2016
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.21299
Subject(s) - nicotinamide , skin cancer , medicine , niacinamide , dermatology , incidence (geometry) , population , oncology , environmental health , cancer , biology , biochemistry , physics , optics , enzyme
Key Points Daily nicotinamide significantly reduced the incidence of nonmelanoma skin cancers in high‐risk individuals. It is reasonable to recommend nicotinamide in high‐risk individuals along with continued sunscreen use and regular skin checks in motivated patients. Further studies including longer follow‐up and a wider population of patients to assess for any unforeseen safety issues as well as efficacy are indicated.